Literature DB >> 10888271

Interaction of histamine and other bioamines with cytochromes P450: implications for cell growth modulation and chemopotentiation by drugs.

F S LaBella1, L J Brandes.   

Abstract

We have characterized microsomal and nuclear histamine sites, designated H(IC), through which this amine acts as an intracellular mediator of platelet aggregation and lymphocyte mitogenesis. A major proportion, at least, of the microsomal H(IC) sites are on cytochromes P450, an important family of microsomal enzymes that are present in all cells, but most abundant in the liver. These enzymes are involved in the metabolism of xenobiotics and natural substrates, including lipid hormones that modulate gene function and cell growth. We have shown that polyamines, hormones (including estrogen, testosterone and progesterone), antihormones (including tamoxifen and flutamide) and various antidepressants and antihistamines, all inhibit histamine binding to P450; we have postulated that, through binding to the heme moiety, intracellular histamine regulates cell function by modulating the catalytic activity of P450 enzymes, an action that may be perturbed by endogenous and exogenous substances. We now demonstrate that, in addition to histamine, melatonin and the biogenic amines dopamine, serotonin and noradrenaline bind to P450 isozymes and to cytochrome C. Thus, heme enzymes in general may represent common targets where multiple bioamines, hormones and drugs interact to influence cell function and growth.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10888271     DOI: 10.1006/scbi.2000.0307

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


  8 in total

1.  Cytochrome P4503A: evidence for mRNA expression and catalytic activity in rat brain.

Authors:  Sanjay Yadav; Alok Dhawan; Prahlad K Seth; Ram L Singh; Devendra Parmar
Journal:  Mol Cell Biochem       Date:  2006-05-04       Impact factor: 3.396

2.  H4 histamine receptors mediate cell cycle arrest in growth factor-induced murine and human hematopoietic progenitor cells.

Authors:  Anne-France Petit-Bertron; François Machavoine; Marie Paule Defresne; Michel Gillard; Pierre Chatelain; Prakash Mistry; Elke Schneider; Michel Dy
Journal:  PLoS One       Date:  2009-08-07       Impact factor: 3.240

Review 3.  Pharmacological potential of biogenic amine-polyamine interactions beyond neurotransmission.

Authors:  F Sánchez-Jiménez; M V Ruiz-Pérez; J L Urdiales; M A Medina
Journal:  Br J Pharmacol       Date:  2013-09       Impact factor: 8.739

4.  Systemic lack of canonical histamine receptor signaling results in increased resistance to autoimmune encephalomyelitis.

Authors:  Naresha Saligrama; Laure K Case; Roxana del Rio; Rajkumar Noubade; Cory Teuscher
Journal:  J Immunol       Date:  2013-06-14       Impact factor: 5.422

5.  Increased apoptosis in osteoclasts and decreased RANKL immunoexpression in periodontium of cimetidine-treated rats.

Authors:  Renata Longhini; Priscila Aparecida de Oliveira; Ana Paula de Souza Faloni; Estela Sasso-Cerri; Paulo Sérgio Cerri
Journal:  J Anat       Date:  2012-12-02       Impact factor: 2.610

6.  A population-based case-control study of Selective Serotonin Reuptake Inhibitors (SSRIs) and breast cancer: the impact of duration of use, cumulative dose and latency.

Authors:  J E Ashbury; L E Lévesque; P A Beck; K J Aronson
Journal:  BMC Med       Date:  2010-12-22       Impact factor: 8.775

7.  Serotonin and dopamine protect from hypothermia/rewarming damage through the CBS/H2S pathway.

Authors:  Fatemeh Talaei; Hjalmar R Bouma; Adrianus C Van der Graaf; Arjen M Strijkstra; Martina Schmidt; Robert H Henning
Journal:  PLoS One       Date:  2011-07-27       Impact factor: 3.240

Review 8.  Histamine: an undercover agent in multiple rare diseases?

Authors:  Almudena Pino-Ángeles; Armando Reyes-Palomares; Esther Melgarejo; Francisca Sánchez-Jiménez
Journal:  J Cell Mol Med       Date:  2012-09       Impact factor: 5.310

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.